NHI reimbursement to grant for 103 new products.

Published: 2005-10-20 06:56:00

Updated: 2005-10-20 06:56:00

The MOHW announced on Oct. 17 that the NHI reimbursement coverage would be extended to 103 new products including 12 orphan drugs for the treatment of multisclerosis and other incurable diseases, for which about 16 billion won of budget be allocated.

So far the NHI reimbursement for injectable...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK